Psilocybin

[Yodean]

I was wondering what Members thought about the emerging psilocybin trend. To me, at least superficially, it is starting to resemble a bit of the early days of the cannabis mania.

I have established small positions in SILO, CMPS, and PLNT.CN (VEGGF in the U.S.).

You need some drugs to go with A.I., methinks.

[SOL]

This company might be a better bet, after it pulls back. With VR, psychdellic drugs are going to be the next frontier, if they are pushed out well, they will overtake the sex industry in terms of demand, but there are going to be a lot of fakers out there to begin


Mind Medicine (MindMed) Inc. (MMEDF)

[Budge]

This company might be a better bet, after it pulls back. With VR, psychdellic drugs are going to be the next frontier, if they are pushed out well, they will overtake the sex industry in terms of demand, but there are going to be a lot of fakers out there to begin


Mind Medicine (MindMed) Inc. (MMEDF)

Sol,
Just dragging you back into the weed(s). In your Dec 22 Financial Blurb article in Tactical Investor on Cannabis you mention Sythian Bioscience. They are now SOL Global Investments SOL.CN, SOLCF. Is there something you're not telling us?

Their largest investment, Verano, is on the acquisition trail:

https://finance.yahoo.com/news/sol-glob ... 00426.html

[Yodean]

With VR, psychdellic drugs are going to be the next frontier, if they are pushed out well, they will overtake the sex industry in terms of demand, but there are going to be a lot of fakers out there to begin

Mind Medicine (MindMed) Inc. (MMEDF)

Thanks! My thoughts exactly. I tend to be a bit early. MMEDF was actually the company that originally brought the emerging psilocybin trend to my attention, but it had such a big parabolic move in mid-December . . . looking at it now, it's corrected some. Might start dipping my toes in this one.

[AstuteShift]

Interesting stocks, I’m sure once cannabis legislation gets in then the government will go on with the more underground drugs

[Yodean]

FWIW, got rid of SILO, CMPS, PLNT.CN, but started establishing a position in MMEDF; also looking at ENBI.CN, which focuses on D.M.T.-based products, apparently; as always, opinions welcome;

Drugs, baby . . .

[Yodean]

The hallucinogenic drug DMT (dimethyltriptamine) could provide crucial aid to stroke victims by minimizing the damage inflicted on victims’ brains as they are rushed to the hospital, according to researchers.

Canadian company Algernon Pharmaceuticals has laid out plans to microdose participants in the first clinical trial of its kind in hopes to help stroke victims’ brains recover faster through a “rewiring” process, reports Metro.

However, researchers at Algernon argue that DMT could play a key role in staving off the worst effects of stroke by sparking the growth of new neurons, effectively turbocharging the healing process.

In the first-ever clinical trials of this kind in the U.S., DMT will soon be administered to stroke patients in the back of ambulances. While the doses will be far too small to trigger any sort of hallucinations, scientists are claiming that the microdoses will still be sufficient for conferring benefits.

The Phase 1 trials could begin as soon as next month, if they receive a green light from authorities. It could still take years before the drug receives approval for human use.

https://www.naturalblaze.com/2021/02/st ... rials.html

[SOL]

The hallucinogenic drug DMT (dimethyltriptamine) could provide crucial aid to stroke victims by minimizing the damage inflicted on victims’ brains as they are rushed to the hospital, according to researchers.

Canadian company Algernon Pharmaceuticals has laid out plans to microdose participants in the first clinical trial of its kind in hopes to help stroke victims’ brains recover faster through a “rewiring” process, reports Metro.

However, researchers at Algernon argue that DMT could play a key role in staving off the worst effects of stroke by sparking the growth of new neurons, effectively turbocharging the healing process.

In the first-ever clinical trials of this kind in the U.S., DMT will soon be administered to stroke patients in the back of ambulances. While the doses will be far too small to trigger any sort of hallucinations, scientists are claiming that the microdoses will still be sufficient for conferring benefits.

The Phase 1 trials could begin as soon as next month, if they receive a green light from authorities. It could still take years before the drug receives approval for human use.

https://www.naturalblaze.com/2021/02/st ... rials.html

So while you hallucinate your heart receives some love, well that would put a new spin on heart treatment. They might have lines that go on for miles.

[Yodean]

MMEDF involved in some pretty innovative activities:

NEW YORK , Feb. 18, 2021 /CNW/ -- MindMed (NEO:MMED) (OTCQB:MMEDF) (DE:MMQ), a leading psychedelic medicine biotech company, announced that it will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.

https://www.barchart.com/story/stocks/q ... ne-company

Here's the CEO:

https://www.kitco.com/news/video/show/M ... t-Analysis

***

MMEDF:
-some "first-mover" advantage;
-involved in primary trends in psychedelic medicine, telehealth, A.I./machine learning, mental health, etc.

*Disclaimer: I have a HODL position.

[Budge]

FWIW, got rid of SILO, CMPS, PLNT.CN, but started establishing a position in MMEDF; also looking at ENBI.CN, which focuses on D.M.T.-based products, apparently; as always, opinions welcome;

Drugs, baby . . .

Long article on CMPS trying to monopolize the market: "Compass Pathways has been aggressively using patent claims to corner the market on psychedelic-assisted treatments."

"After assembling a phalanx of patent lawyers, Compass Pathways began filing broad claims to control key synthetic versions of psilocybin, the psychoactive component in magic mushrooms, as well as its therapeutic application for patients. Now the highest-valued publicly traded company in the magic mushroom market, Compass has amassed a war chest of U.S. patents, with a large application of claims under review by international patent authorities. It has also secured FDA “breakthrough therapy” designation, which virtually guarantees that it will be first to market."

https://prospect.org/power/rollups-emer ... -monopoly/

[Yodean]

Long article on CMPS trying to monopolize the market: "Compass Pathways has been aggressively using patent claims to corner the market on psychedelic-assisted treatments."

"After assembling a phalanx of patent lawyers, Compass Pathways began filing broad claims to control key synthetic versions of psilocybin, the psychoactive component in magic mushrooms, as well as its therapeutic application for patients. Now the highest-valued publicly traded company in the magic mushroom market, Compass has amassed a war chest of U.S. patents, with a large application of claims under review by international patent authorities. It has also secured FDA “breakthrough therapy” designation, which virtually guarantees that it will be first to market."

https://prospect.org/power/rollups-emer ... -monopoly/

I think once the cannabis trend regains some traction, likely this year or next, psilocybin will follow. RT play MNMD should do well, but we might be in for a bit of a wait ...